Categories
Tags
Abbott Advertising AstraZeneca Barack Obama Biotechnology and Pharmaceuticals Breast cancer Bristol Myers Squibb business Cancer Clinical trial Conditions and Diseases Deal Eli Lilly European Commission European Union FDA Food and Drug Administration Genentech generics GlaxoSmithKline Google GSK HBA Health Health care Johnson & Johnson layoffs Lilly Margaret Hamburg Marketing Merck Novartis Pfizer Pharma Pharmaceutical drug pharmaceutical industry Research and development Roche Sanofi-Aventis Schering Plough social media Twitter U.S. Food and Drug Administration United States Wyeth
Technology News
BioPharm News- Shire Gains European Approval for its Gaucher Disease Treatment
- Mtech Bioprocess Scale-Up Facility to Double in Staff and Size
- ImClone Closes Plant in New Jersey, Consolidating Erbitux Manufacture
- EMA and FDA Seek Applicants for Joint GMP Inspections
- ATMI Expands Bloomington, Minnesota Manufacturing Facility
Clinical Trials News- CRF Health Achieves EXACT ePRO Vendor Certification for Windows Mobile Systems
- ACR Image Metrix Establishes Global Presence
- BioPharm Systems Named to the 2010 Inc. 500|5000 List of Fastest-Growing Companies in the U.S.
- CRF Health Doubles North American Headquarters
- Oracle Completes Acquisition of Phase Forward
Blogroll
-
Meta
Tag Archives: Canada
Pharma Unplugged #2 Layoffs & Bonuses
Pharma Unplugged #2— Layoffs & Bonuses
Recorded: 12/3/2009
Air Date: 12/7/2009
Host: George Koroneos, Pharm Exec
Cohost: Reid Paul, Pharm Rep Magazine
Show Notes:
This week we discuss:
Pfizer’s medical education relationship with the Canadian Medical Association
Journalists take FDA to task for not being transparent enough
Layoffs and job cuts at Sanofi-Aventis
New report shows that DTC receives more funding than sales calls in [...]
Posted in News, Podcasts Also tagged Food and Drug Administration, Medicine, pharma unplugged, podcast, Sanofi-Aventis Leave a comment
H1N1 Vaccine Quantities to Fall Short of Predictions
Image by â– Guerry via Flickr
The US may not have as many H1N1 flu vaccines available from the get-go as originally anticipated, CBS News reported on Tuesday.
According to the report, approximately 45 million doses will be available in mid-October—that’s down from the original plan of 120 million doses. The new plan calls for [...]
Posted in Manufacturing Also tagged GlaxoSmithKline, Health, Influenza, Influenza A virus subtype H1N1, Influenza pandemic, Influenza vaccine 2 Comments
GSK Signs $120M Deal to Market DMab Overseas
Image via Wikipedia
In an effort to boost its sales force without hiring more sales reps, Amgen announced on Tuesday that it has signed a deal with GlaxoSmithKline to co-market its osteoporosis treatment denosumab—currently pending FDA approval.
GSK will paying $120 million up front (along with royalties) to mutually market denosumab, or DMab, in regions where Amgen [...]
Posted in Deals, News, Technology Also tagged Amgen, Australia, denosumab, Dmab, GlaxoSmithKline, Market, Mexico, New Zealand, sales force, U.S. Food and Drug Administration, United States Leave a comment

Merck to Close Eight Plants